Open labeled phase II observation study of gemcitabine plus cisplatin plus trastuzumab (GCT) in metastatic breast cancer patients with prior anthracyclines and taxanes exposures: Preliminary results

Mutlu Demiray,Turkkan Evrensel,Ozkan Kanat,Ender Kurt,Murat Arslan,Sehsuvar Gokgoz,Şahsine Tolunay,Osman Manavoglu

Open labeled phase II observation study of gemcitabine plus cisplatin plus trastuzumab (GCT) in metastatic breast cancer patients with prior anthracyclines and taxanes exposures: Preliminary results

2006

Mutlu Demiray
Turkkan Evrensel
Ozkan Kanat
Ender Kurt
Murat Arslan
Sehsuvar Gokgoz
Şahsine Tolunay
Osman Manavoglu

10720 Background: Trastuzumab provides significant clinical benefit in HER2 positive metastatic breast cancer. Gemcitabine and cisplatin (GC) combination is attractive treatment options for anthrac...

Keywords:

Trastuzumab
Gemcitabine
Cisplatin
Oncology
Internal medicine
Cancer research
Medicine
Metastatic breast cancer
treatment options

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations